Indivior Pharmaceuticals Inc. share price logo

Indivior Pharmaceuticals Inc.

NASDAQ: INDV

Mid Cap

$40.22

-0.28

(-0.70%)

as on

Indivior Pharmaceuticals Inc. Stock Performance

as on July 14, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $39.25
    $40.47
    downward going graph

    2.41%

    Downside

    0.62%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $15.00
    $42.81
    downward going graph

    62.71%

    Downside

    6.44%

    Upside

    downward going graph

Indivior Pharmaceuticals Inc. share price movements today

Previous Close
$40.50
Open
$40.02
Volume
728.0K
Day's Low - High
$39.25 - $40.47
52 Week Low - High
$15.00 - $42.81

Indivior Pharmaceuticals Inc. Historical Returns

1 Month Return
+ 5.25 %
3 Month Return
+ 22.84 %
1 Year Return
+ 159.28 %
3 Year Return
+ 73.5 %
5 Year Return
0 %

Indivior Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Indivior Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.8B

EPS (TTM)

3.8248

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.82%

PE Ratio (TTM)

21.2

Industry PE ratio

32.183

PEG Ratio

0

EBITDA

475.0M

Revenue (TTM)

1.3B

Profit Margin

19.53%

Return On Equity TTM

12.20%

Indivior Pharmaceuticals Inc. Stock Valuation

Track how Indivior Pharmaceuticals Inc. P/E has moved over time to understand its valuation trends.

Indivior Pharmaceuticals Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-108.16x)

September 30, 2023

Today (21.20x)

July 14, 2026

Industry (32.18x)

July 14, 2026

Highest (12.41x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 21.20x

Indivior Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Indivior Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Indivior Pharmaceuticals Inc. image
Indivior Pharmaceuticals Inc.
BUY$4.8BNA21.219.53%NA
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$23.2B197.98%20.2540.62%NA
Viatris Inc. image
Viatris Inc.
HOLD$18.9B15.64%NA-2.04%2.94%
Haleon plc (ADR) image
Haleon plc (ADR)
BUY$43.0BNA19.9215.11%1.9800000000000002%
ZOETIS INC. image
ZOETIS INC.
BUY$31.7B-62.46%12.3928.04%2.7%
See all

Stock Returns calculator for Indivior Pharmaceuticals Inc. Stock including INR - Dollar returns

The Indivior Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Indivior Pharmaceuticals Inc. investment value today

Current value as on today

₹2,86,224

Returns

₹1,86,224

(+186.22%)

Returns from Indivior Pharmaceuticals Inc. Stock

₹1,57,490 (+157.49%)

Dollar Impact

₹28,733 (+28.73%)

Analyst Recommendation on Indivior Pharmaceuticals Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Indivior Pharmaceuticals Inc.. Average target price of $50.83

Indivior Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Indivior Pharmaceuticals Inc..

What analysts predicted

20.87%UPSIDE

Target Price

$50.83

Current Price

$40.22

Analyzed by

7 Analysts

Target

$50.83

Indivior Pharmaceuticals Inc. target price $50.83, a slight upside of 20.87% compared to current price of $40.22. According to 7 analysts rating.

Indian Investors' Interest in Indivior Pharmaceuticals Inc. Stock

Search interest for Indivior Pharmaceuticals Inc. Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-43% versus previous 30 day period

Indivior Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
293
284
299
307
299
266
302
314
358
316
Gross Profit
242
246
220
238
276
222
250
252
294
276
Operating Income
61
75
-118
4
96
66
72
99
122
137
EBITDA
79
87
-106
22
106
76
82
54
92
123
Interest Expense
9
8
9
10
13
12
15
12
6
6
Depreciation
9
9
25
-10
5
5
5
5
5
4
Income Before Tax
62
73
-121
-1
88
59
62
37
81
115
Income Tax Expense
8
11
-23
-5
28
11
44
-5
-21
25
Net Income
54
61
-97
4
59
47
18
42
102
88
Net Profit Margin
18.43%
21.48%
-32.44%
1.30%
19.73%
17.67%
5.96%
13.38%
28.49%
28.08%

Indivior Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
968
1,148
959
785
647
791
901
1,093
1,188
1,239
Gross Profit
858
1,025
825
645
550
664
750
919
957
993
Operating Income
337
423
317
178
-156
213
-81
-156
32
265
EBITDA
149
436
310
230
-123
238
-46
-99
84
304
Interest Expense
51
49
31
22
24
26
29
35
41
45
Depreciation
-
-
-
28
26
22
21
28
29
20
Income Before Tax
89
143
265
180
-173
190
-89
-149
14
239
Income Tax Expense
57
82
2
46
-25
-15
-44
-20
11
29
Net Income
32
60
262
134
-148
205
-44
-129
2
210
Net Profit Margin
3.31%
5.31%
27.36%
17.07%
-22.87%
25.92%
-4.88%
-11.80%
0.17%
16.95%

Indivior Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
46
-107
3
20
47
18
43
102
89
Operating Cash Flow
-54
87
8
-5
75
166
-39
-221
-9
Investing Cash Flow
24
1
32
9
-5
-18
-20
-24
-19
Financing Cash Flow
-37
-34
-55
29
-17
-4
-3
-5
7
Change in Cash
-67
54
-14
31
53
138
-65
-250
-20

Indivior Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
60
262
178
-156
213
-44
-129
2
210
Operating Cash Flow
309
289
151
-193
353
-4
-300
36
-27
Investing Cash Flow
-45
-3
-2
-4
-14
-222
-95
69
-66
Financing Cash Flow
-88
-226
-13
-10
-94
-101
-64
-102
-30
Change in Cash
171
60
136
-202
244
-328
-458
3
-124

Global Institutional Holdings in Indivior Pharmaceuticals Inc.

Funds
Holdings
The Goldman Sachs Group Inc
2.04%
Amvescap Plc.
1.28%
Two Seas Capital LP
4.02%
Millennium Management LLC
3.89%
Fuller & Thaler Asset Management Inc
3.83%
See all

Indivior Pharmaceuticals Inc. News & Key Events

  • img

    Today's Timeline - 23 June

    Tue, 08:37 PM

    -

    Indivior Pharmaceuticals sees EPS estimates rise for 2026 and 2027, with shares up 6.8% year to date.

Insights on Indivior Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, INDV has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, INDV has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, INDV stock has moved up by 159.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 358.00M → 316.99M (in $), with an average decrease of 11.5% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 102.00M → 88.99M (in $), with an average decrease of 12.8% per quarter

About Indivior Pharmaceuticals Inc.

Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. The company was formerly known as Indivior PLC. and changed its name to Indivior Pharmaceuticals, Inc. in January 2026. Indivior Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
OrganisationIndivior Pharmaceuticals Inc.
Headquarters10710 Midlothian Turnpike, North Chesterfield, VA, United States, 23235
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Joseph J. Ciaffoni
E-voting on sharesClick here to vote

Key Management of Indivior Pharmaceuticals Inc.

Name

Title

Mr. Kevin L. Espinoza

Chief Integrity & Compliance Officer

Ms. Vanessa Procter

Executive Vice President of Corporate Affairs

Ms. Alice G. Givens

Company Secretary

Mr. Joseph J. Ciaffoni

CEO & Director

Mr. Jeffrey W. Burris J.D.

Chief Legal Officer

Mr. Patrick a. Barry

Chief Commercial Officer

Mr. Jason Thompson

Vice President of Investor Relations

Mr. Ryan Preblick

Chief Financial Officer

Dr. Christian Heidbreder

Chief Scientific Officer

Ms. Angela Colon-Mahoney M.S.

Chief Human Resources Officer

FAQs

What is Indivior Pharmaceuticals Inc. share price today?

Indivior Pharmaceuticals Inc. share price today is $40.22 as on at the close of the market. Indivior Pharmaceuticals Inc. share today touched a day high of $40.47 and a low of $39.25.

What is the 52 week high and 52 week low for Indivior Pharmaceuticals Inc. share?

Indivior Pharmaceuticals Inc. share touched a 52 week high of $42.81 on and a 52 week low of $15.00 on . Indivior Pharmaceuticals Inc. stock price today i.e. is closed at $40.22,which is 6.05% down from its 52 week high and 168.13% up from its 52 week low.

What is Indivior Pharmaceuticals Inc.'s market capitalisation today?

Indivior Pharmaceuticals Inc. market capitalisation is $0.00T as on .

How to invest in Indivior Pharmaceuticals Inc. Stock (INDV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Indivior Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Indivior Pharmaceuticals Inc. Shares that will get you 0.0373 shares as per Indivior Pharmaceuticals Inc. share price of $40.22 per share as on July 14, 2026 at 1:29 am IST.

What is the minimum amount required to buy Indivior Pharmaceuticals Inc. Stock (INDV) from India?

Indian investors can start investing in Indivior Pharmaceuticals Inc. (INDV) shares with as little as ₹95.615 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.15 in Indivior Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Indivior Pharmaceuticals Inc. share’s latest price of $40.22 as on July 14, 2026 at 1:29 am IST, you will get 0.2486 shares of Indivior Pharmaceuticals Inc.. Learn more about fractional shares .